Literature DB >> 25795749

Trigeminal herpes zoster: early recognition and treatment are crucial.

Ben Lovell1.   

Abstract

Reactivation of varicella zoster virus (VZV) is not uncommon in older patients, particularly in cases of chronic autoimmune disorders and in patients taking immunosuppressant drugs. We present a case of a 57-year-old woman presenting with severe herpes zoster infection, involving the maxillary and ophthalmic branches of the trigeminal nerve. Despite an initial delay in instigating crucial antiviral treatment, the patient achieved an excellent recovery, with only some mild scarring at 2 months postinfection. Trigeminal herpes zoster is a potentially devastating clinical occurrence, and is associated with severe long-term neurological sequelae, including encephalitis, vision loss and postherpetic neuralgia. Physicians must be aware of risk factors and treatment modalities. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795749      PMCID: PMC4369019          DOI: 10.1136/bcr-2014-208673

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  The global epidemiology of herpes zoster.

Authors:  Barbara P Yawn; Don Gilden
Journal:  Neurology       Date:  2013-09-03       Impact factor: 9.910

Review 2.  Managing ophthalmic herpes zoster in primary care.

Authors:  Wim Opstelten; Michel J W Zaal
Journal:  BMJ       Date:  2005-07-16

Review 3.  Corticosteroids for preventing postherpetic neuralgia.

Authors:  Ying Han; Jingjing Zhang; Ning Chen; Li He; Muke Zhou; Cairong Zhu
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

4.  The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature.

Authors:  Luisa Di Costanzo; Fabio Ayala; Matteo Megna; Francesca Gaudiello; Angela Patrì; Nicola Balato
Journal:  J Dermatol Case Rep       Date:  2013-03-30

5.  Herpes zoster vaccination in SLE: a pilot study of immunogenicity.

Authors:  Joel M Guthridge; Abigail Cogman; Joan T Merrill; Susan Macwana; Krista M Bean; Tiny Powe; Virginia Roberts; Judith A James; Eliza F Chakravarty
Journal:  J Rheumatol       Date:  2013-09-15       Impact factor: 4.666

Review 6.  Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies.

Authors:  Alejandro Souto; José Ramón Maneiro; Eva Salgado; Loreto Carmona; Juan J Gomez-Reino
Journal:  Rheumatology (Oxford)       Date:  2014-05-11       Impact factor: 7.580

7.  Quantification of risk factors for herpes zoster: population based case-control study.

Authors:  Harriet J Forbes; Krishnan Bhaskaran; Sara L Thomas; Liam Smeeth; Tim Clayton; Sinéad M Langan
Journal:  BMJ       Date:  2014-05-13
  7 in total
  2 in total

1.  Herpes zoster ophthalmicus caught in the (Tr)act!

Authors:  Musa Mufti; Christopher Shackles; Emaan Alvi; Jaya Nath
Journal:  Emerg Radiol       Date:  2018-07-10

2.  Efficacy of CT Guided Pulsed Radiofrequency Treatment for Trigeminal Postherpetic Neuralgia.

Authors:  Yuanyuan Ding; Tao Hong; Hongxi Li; Peng Yao; Guangyi Zhao
Journal:  Front Neurosci       Date:  2019-07-09       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.